Aphasia
Conditions
Interventions
Thirty male and female adults will participate in this study and will be randomly allocated to the neuromodulation and motor therapy group, neuromodulation and language therapy group or control group
E02.331.750
Sponsors
Universidade Federal de Sergipe
Programa de Pós-graduação em ciências aplicadas à Saúde (PPGCAS)
Eligibility
Age
30 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients aged between 30 and 80 years will be included; of both sexes, diagnosis of ischemic or hemorrhagic stroke confirmed by computed tomography or magnetic resonance imaging, absence of cognitive deficits (assessed by the MMSE - Mini Mental State Examination, score greater than 18 ; All degrees of motor impairment according to the classification Fugl-Meyer score (total score 0 to 66 points): severe (Fugl-Meyer score 0 to 15 points), severe or moderate (16 to 34 Fugl-Meyer points), moderate/mild (35-53 Fugl points -Meyer) and mild (54 to 66 Fugl Meyer points); Aphasic patients will be evaluated by the Boston Naming Test and Montreal-Toulouse Battery Test (MTL-Brazil), in all degrees of impairment: alert for neuropsychological deficit (- 1.0 and -1.5), moderate to severe deficit (-1.6 and -2.0), presence of very severe deficit (less than or equal to -2.0), does not suggest cognitive deficit (greater than - 1.0)
Exclusion criteria
Exclusion criteria: Patients who present the following conditions will be excluded: clinical evidence of multiple brain lesions or other associated neurological diseases; peripheral neuropathies, leprosy, fibromyalgia, rheumatoid arthritis; other upper and lower motor neuron pathologies; history of psychiatric illness including drug and alcohol abuse; orthopedic deformities installed in the upper limbs. Those who are undergoing rehabilitation treatment during the collection (Occupational Physiotherapy and/or Speech Therapy) will not participate in the research. Patients with receptive types of aphasia (assessed by the MTL-Brazil test) will also be excluded. In addition to these, due to contraindication for the application of tDCS, patients with intracranial metallic implants will be excluded; pregnancy; use of medication that interferes with cortical excitability; history of seizures and/or epilepsy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a relationship between upper limb motor function and language functions by the degree of impairment of these skills in order to establish a predictive factor of recovery and to investigate whether central therapy associated with peripheral may be superior to increase function in both. the functions (motor and language) | — |
Secondary
| Measure | Time frame |
|---|---|
| We will observe the motor and language skills by level of severity of the injury, as well as the correlation of upper limb motor function with language | — |
Countries
Brazil
Contacts
Public ContactValquiria Seixas
Universidade Federal de Sergipe
Outcome results
None listed